| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |